We are live on ! Find out more
MDWD icon

MediWound

63 hedge funds and large institutions have $76M invested in MediWound in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 3

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

86% more capital invested

Capital invested by funds: $40.8M → $76M (+$35.2M)

40% more funds holding

Funds holding: 4563 (+18)

10.63% more ownership

Funds ownership: 28.35%38.98% (+11%)

0% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 17

69% less call options, than puts

Call options by funds: $460K | Put options by funds: $1.49M

Holders
63
Holders Change
+18
Holders Change %
+40%
% of All Funds
0.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
21
Increased
17
Reduced
17
Closed
3
Calls
$460K
Puts
$1.49M
Net Calls
-$1.03M
Net Calls Change
-$614K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$293K -$106K -5,793 -26%
Goldman Sachs
27
Goldman Sachs
New York
$249K +$252K +13,811 New
Point72 Asset Management
28
Point72 Asset Management
Connecticut
$212K +$214K +11,727 New
Barclays
29
Barclays
United Kingdom
$202K +$154K +8,449 +311%
Pathstone Holdings
30
Pathstone Holdings
New Jersey
$196K
N
31
Nuveen
North Carolina
$195K
RJA
32
Raymond James & Associates
Florida
$191K +$193K +10,593 New
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$182K +$30.2K +1,656 +20%
Osaic Holdings
34
Osaic Holdings
Arizona
$123K +$16.4K +900 +15%
Bank of America
35
Bank of America
North Carolina
$104K +$4.22K +231 +4%
Citigroup
36
Citigroup
New York
$102K +$71.3K +3,906 +224%
Deutsche Bank
37
Deutsche Bank
Germany
$102K +$98.2K +5,379 +2,160%
MIM
38
MetLife Investment Management
New Jersey
$89.3K +$90.3K +4,946 New
Mirae Asset Global ETFs Holdings
39
Mirae Asset Global ETFs Holdings
Hong Kong
$80.1K +$80.9K +4,434 New
CF
40
Corebridge Financial
Texas
$75.6K -$2.21K -121 -3%
UBS Group
41
UBS Group
Switzerland
$66.5K +$3.69K +202 +6%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$63.2K -$60.2K -3,300 -49%
JP Morgan Chase
43
JP Morgan Chase
New York
$61.4K -$1.38M -75,360 -96%
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
$56K +$42.9K +2,353 +312%
Acadian Asset Management
45
Acadian Asset Management
Massachusetts
$44K +$44.8K +2,452 New
Legal & General Group
46
Legal & General Group
United Kingdom
$16K
TRCT
47
Tower Research Capital (TRC)
New York
$15.2K +$14.1K +771 +1,086%
BTI
48
Blue Trust Inc
Georgia
$14.6K +$17.2K +940 New
AIP
49
Ameritas Investment Partners
Nebraska
$14.2K
Russell Investments Group
50
Russell Investments Group
United Kingdom
$13.6K +$13.8K +754 New

MDWD Hedge Fund Activity: Q3 2024 in Review

63 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in MediWound (MDWD) for Q3 2024, worth a combined $76M — up 86% from $40.8M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new MDWD positions and 3 closed out — a net gain of 18 holders — while 17 added to existing stakes and 17 trimmed.

The largest buyer was Investor AB, opening a new position worth an estimated $15.9M. The largest seller was JP Morgan Chase, cutting an estimated $1.38M.

  • 63 institutional investors held MediWound (MDWD) as of Q3 2024, up from 45 in Q2 2024.
  • Funds reported $76M of MediWound stock for Q3 2024, up 86% quarter-over-quarter.
  • 21 funds opened new MediWound positions in Q3 2024 and 3 closed out, a net change of +18 holders.
  • The largest MediWound buyer in Q3 2024 was Investor AB, an estimated $15.9M added.
  • The largest MediWound seller in Q3 2024 was JP Morgan Chase, an estimated $1.38M sold.

Based on aggregated 13F filings for Q3 2024.